Cancer NetworkOriginal article
<![CDATA[Agenus Discontinues Phase 3 BATTMAN Trial in Metastatic MSS Colorectal Cancer]]>
Phase 3negativeNegative
AI Analysis
Summary
Agenus has discontinued financial support for the Phase 3 BATTMAN trial in late-line metastatic MSS colorectal cancer to redirect resources toward neoadjuvant development of the same therapeutic regimen.
Clinical Trial Data
Phase
3
Primary Endpoint
Not Met
Outcome Details
Trial discontinued; financial support halted
Importance:6/10
Sentiment:
-0.80
Phase 3 discontinuationcolorectal cancermetastatic MSSdevelopment strategy shift
Related Companies
Read the original article
Published by Cancer Network on July 14, 2026 3:15 PM